Melissa Oropeza

From Wikipedia, the free encyclopedia
Melissa Oropeza
Member of the Kansas House of Representatives
from the 37th district
Assumed office
January 9, 2023
Preceded byAaron Coleman
Personal details
BornWyandotte County, Kansas, U.S.
Political partyDemocratic
EducationKansas City Kansas Community College
University of Kansas (BSN, MSN)
University of Missouri-Kansas City (DNP)
WebsiteCampaign website

Melissa Oropeza is an American politician serving as a member of the Kansas House of Representatives from the 37th district. Her term began on January 9, 2023.[1]

Biography[edit]

Oropeza was born and raised in Wyandotte County, Kansas, and graduated from Turner High School. She attended Kansas City Kansas Community College and received her associate degree in nursing. She then attended the University of Kansas, where she received a Bachelor of Science in Nursing and a Master of Science in Nursing. She received her Doctor of Nursing Practice from the University of Missouri-Kansas City in 2020. Prior to entering politics, she worked as a registered nurse, a gastroenterology nurse practitioner, and as a member of the Kansas State Board of Nursing.[1][2][3][4][5]

Electoral history[edit]

Kansas House of Representatives 37th District 2022 Democratic Primary[2]
Party Candidate Votes %
Democratic Melissa Oropeza 1,203 49.2%
Democratic Faith Rivera 923 37.7%
Democratic Aaron Coleman (incumbent) 321 13.1%
Total votes 1,203 100.00

References[edit]

  1. ^ a b "Representative Melissa Oropeza". Kslegislature.org. Retrieved 17 July 2023.
  2. ^ a b Ritter, Sarah (August 3, 2022). "Kansas Rep. Aaron Coleman, with history of abuse, loses seat in Democratic primary". The Kansas City Star.
  3. ^ Ujiyediin, Nomin (28 October 2022). "In the wake of a scandal-plagued lawmaker, Wyandotte County will choose between two newcomers". KCUR. Retrieved 17 July 2023.
  4. ^ "About". Oropeza for Kansas. Retrieved 17 July 2023.
  5. ^ "Board Members". Kansas State Board of Nursing. Archived from the original on 15 March 2023. Retrieved 17 July 2023.